Editor
Panel biomarker testing can unlock some of the mysteries of treating patients so that they experience fewer side effects, better quality of life, longer survival rates and potentially, lower costs. At least 22 states are opening up, or looking at how to open up, access to it.
This past week, New York Governor Kathy Hochul signed Senate Bill 1196a/Assembly Bill 1673a into law, which directs all state-regulated health plans, including…
